Twitter used to research misconceptions about illnesses

By Admin
Mark Dredze and Michael Paul, computer scientists at John Hopkins University, collected and assessed 1.5 million tweets, all up to 140 characters in le...

Mark Dredze and Michael Paul, computer scientists at John Hopkins University, collected and assessed 1.5 million tweets, all up to 140 characters in length, posted between May 2009 and October 2010.

Their computer system discarded irrelevant tweets and sorted the data into categories such as flu, allergies, insomnia, cancer and depression.

They then analysed the data to infer how users were treating their illnesses.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

“We found that some people tweeted that they were taking antibiotics for flu. But antibiotics don't work on the flu, which is a virus, and this practice could contribute to the growing antibiotic resistance problems,” said Paul.

“So these tweets showed us that some serious medical misperceptions exist out there.”

They will present their research at the International Conference on Weblogs and Social Media, which is sponsored by the Association for the Advancement of Artificial Intelligence.  

Dredze and Paul have already been in talks with public health scientists, who agree Twitter may be a useful resource for analysing public perceptions of illnesses.

However, as with all social media, Twitter’s use as a research tool is limited.

“In our study we could only learn what people were willing to share,” Paul remarked. “We think there's a limit to what people are willing to share on Twitter.”


Share

Featured Articles

Grifols & Orange Business Launch Egypt Plasma Project

Grifols & Orange Business Complete landmark phase of Data Centre for Plasma Derivatives Facility, designed to boost healthcare in Egypt

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Medical Devices & Pharma

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain